Eilika Weber-Ban Lab
banner
ewb-lab.bsky.social
Eilika Weber-Ban Lab
@ewb-lab.bsky.social
We study proteostasis and cellular degradation machines in mycobacteria.
weber-ban-lab.ethz.ch
Reposted by Eilika Weber-Ban Lab
Asgard archaea were first found in mud at the bottom of the North Sea. Today, cellular biologists Martin Pilhofer and Christa Schleper are exploring one of their more elusive structural elements: a totally tubular system that looks a lot like our own.
www.quantamagazine.org/tiny-tubes-r...
September 9, 2025 at 3:46 PM
We are currently witnessing the complete succumbing to blackmail of the so-called civilized world. The speed of general moral and ethical decline in the name of economic constraints and reasoning is shocking. We must be aware that scientific integrity will not escape untouched.
August 9, 2025 at 9:13 AM
Proud of my doctoral student Charlotte Schilling who successfully defended her thesis today! Congratulations, ⁦‪Charlotte, on an excellent job! 👏🥂
July 3, 2025 at 8:53 PM
Reposted by Eilika Weber-Ban Lab
Check out our latest preprint with the Qi lab on the structure and disease physiology of the human ERAD complex. Outstanding work by Leo, a cell physiologist whom we successfully tempted into structural biology! Preprint: www.biorxiv.org/content/10.1...
June 16, 2025 at 2:42 PM
Reposted by Eilika Weber-Ban Lab
Muñoz-Hernández, Xu, et al. @mike-wieczorek.bsky.social @ethz.ch report #cryoEM structures revealing how NEDD1’s C terminus forms an α-helical tetramer that docks onto the γ-TuRC without inducing major conformational changes in the complex during its recruitment to MTOCs rupress.org/jcb/article/...
May 21, 2025 at 4:10 PM
Congratulations to our colleague Jörn Piel and the other awardees! nachrichten.idw-online.de/2025/05/15/j...
Jung-Stiftung zeichnet wegweisende Forschungsansätze aus
nachrichten.idw-online.de
May 15, 2025 at 8:26 AM
Reposted by Eilika Weber-Ban Lab
Breaking news and a great honour for D-BIOL professor Jörn Piel: he wins the very prestigious Jung Prize for Medicine! Our congratulations! ethz.ch/en/news-and-...
ETH microbiologist honoured with prestigious European medical award
Chemist and microbiologist Jörn Piel combs through the vast world of bacteria for new natural substances to combat the antibiotic crisis. The ETH professor has now been honoured for his research with ...
ethz.ch
May 15, 2025 at 6:13 AM
Reposted by Eilika Weber-Ban Lab
🧵5 Top Free Alternatives to BioRender for Scientific Illustrations!

These five websites offer free scientific illustrations for biologists. Great for presentations, research papers and other research communication needs.

Save and share the post!
May 13, 2025 at 7:55 PM
As scientists we must be ready to communicate the importance of vaccination wherever the discussion may come up, with family, friends or at the hair dresser. Be prepared to explain in a fact-based and accessible manner.
Combating vaccine revisionism - Nature Medicine
The scientific community must take a strong and active stand against vaccine revisionism — the false narrative that there is insufficient evidence to support the safety and efficacy of vaccines.
www.nature.com
April 22, 2025 at 10:15 AM
Check out our new study revealing how ATP-independent activator Bpa binds asymmetrically to the Mtb #proteasome — and pinpointing key Bpa residues involved in substrate interaction.
👏 Tatjana v. Rosen, Rafal Zdanowicz & @yasser-elhadeg.bsky.social
🔗 www.nature.com/articles/s41...
Substrates bind to residues lining the ring of asymmetrically engaged bacterial proteasome activator Bpa - Nature Communications
Mycobacterium tuberculosis has a proteasome similar to eukaryotes. This study reveals how the activator Bpa recruits its substrate HspR, providing structural and mechanistic insights. The authors iden...
www.nature.com
March 28, 2025 at 4:02 PM
Reposted by Eilika Weber-Ban Lab
Asgard archaea have actin - but what about microtubules? Where do they come from? 🧐 Our new paper www.cell.com/cell/fulltex... by @xujwet.bsky.social & @florianwollweber.bsky.social, in collaboration with the Schleper & Wieczorek labs, describes tiny Asgard microtubules! #TeamTomo #ArchaeaSky 1/6
March 21, 2025 at 3:16 PM
Reposted by Eilika Weber-Ban Lab
More than 2 decades ago the PINK1 protein was found to be linked to Parkinson's disease, but its structure and how it was activated was not known. Until @science.org today. A triumph for cryo-EM and structural biology, introducing new targets for drug intervention.
www.science.org/doi/10.1126/...
March 13, 2025 at 11:19 PM
Reposted by Eilika Weber-Ban Lab
Thank you, Annette, for taking on this important responsibility!
Annette Oxenius has been appointed ETH Vice President for Research. From 1 August 2025, she will assume responsibility for research development and promotion at ETH Zurich. The 56-year-old Swiss national is an esteemed immunologist and professor at the ETH Department of Biology.

Read more:
Fundamental and applied research are two sides of the same coin
Annette Oxenius has been appointed ETH Vice President for Research. From 1 August 2025, she will assume responsibility for research development and promotion at ETH Zurich. The 56-year-old Swiss natio...
ethz.ch
March 6, 2025 at 5:58 PM
Fully agree! “Peer” review being the important aspect here. And yes, reviewing takes time, as it should.
March 6, 2025 at 6:41 AM
Reposted by Eilika Weber-Ban Lab
Some good news! The final program for the inaugural #GRCBiologyofMycobacteria is up! We are also officially oversubscribed but cancellations happen... www.grc.org/biology-of-m...
2025 Biology of Mycobacteria Conference GRC
The 2025 Gordon Research Conference on Biology of Mycobacteria will be held in Pomona, California. Apply today to reserve your spot.
www.grc.org
February 27, 2025 at 12:17 AM
Reposted by Eilika Weber-Ban Lab
A new study from the Weber-Ban lab led by Charlotte Schilling @cm_schilling with support from @rafal_Zdanowicz @Glockshuber_lab reveals the signal linking DNA damage to the activation of the mycobacterial DNA damage response. More: biol.ethz.ch/en/news-and-...
February 18, 2025 at 7:31 AM